Literature DB >> 17597996

Factor XI in haemostasis and thrombosis: past, present and future.

Uri Seligsohn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597996

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  18 in total

1.  Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events.

Authors:  Anetta Undas; Agnieszka Slowik; Matthew Gissel; Kenneth G Mann; Saulius Butenas
Journal:  Eur J Clin Invest       Date:  2011-06-27       Impact factor: 4.686

2.  Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation.

Authors:  Milosz Jankowski; Anetta Undas; Przemyslaw Kaczmarek; Saulius Butenas
Journal:  Thromb Res       Date:  2011-01-13       Impact factor: 3.944

3.  Successful perioperative management in a patient with factor XI deficiency.

Authors:  Margaret L McCarthy; Sarah M Ordway; Ryan M Jones; Jeremy G Perkins
Journal:  BMJ Case Rep       Date:  2018-02-21

4.  Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy.

Authors:  Michał Zabczyk; Saulius Butenas; Ilona Palka; Jadwiga Nessler; Anetta Undas
Journal:  Pol Arch Med Wewn       Date:  2010-09

Review 5.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

6.  Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.

Authors:  Anetta Undas; Agnieszka Slowik; Matthew Gissel; Kenneth G Mann; Saulius Butenas
Journal:  Thromb Res       Date:  2011-08-04       Impact factor: 3.944

7.  Factor XI contributes to thrombin generation in the absence of factor XII.

Authors:  Dmitri V Kravtsov; Anton Matafonov; Erik I Tucker; Mao-Fu Sun; Peter N Walsh; Andras Gruber; David Gailani
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

8.  Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.

Authors:  Rami A Al-Horani; Pooja Ponnusamy; Akul Y Mehta; David Gailani; Umesh R Desai
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

Review 9.  Update on the physiology and pathology of factor IX activation by factor XIa.

Authors:  Stephen B Smith; David Gailani
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

Review 10.  Structural and functional features of factor XI.

Authors:  D Gailani; S B Smith
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.